Biotest AG (ETR:BIO) | WebDisclosure

Basculer en Français

9480	Companies
185543	Keywords
117939	Articles
99384	Press releases

Home
Companies
Biotest AG

PRESS RELEASE

published on 11/15/2024 at 09:00, 1 year ago

Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt and call for plasma donations
Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt to promote plasma donations and secure the long-term supply of plasma. Biotest AG emphasizes the importance of plasma donation in treating various illnesses

Community Support Healthcare Biotest AG Plasma Donations Plasma Center
BRIEF

published on 11/14/2024 at 10:19, 1 year ago

Biotest annonce une augmentation de son chiffre d'affaires de 4,5 % au cours des neuf premiers mois de 2024

Perspectives Financières Chiffre D'affaires De Biotest Croissance De Yimmugo® Fibrinogène BT524 Accord Grifols
BRIEF

published on 11/14/2024 at 10:19, 1 year ago

Biotest Reports 4.5% Revenue Increase in First Nine Months of 2024

Financial Outlook Biotest Revenue Yimmugo® Growth Fibrinogen BT524 Grifols Agreement
PRESS RELEASE

published on 11/14/2024 at 10:14, 1 year ago

Biotest increases revenues in the first 9 months by 4.5% to Euro 523 million
Biotest AG reports 4.5% revenue growth in first 9 months, reaching Euro 523 million. Product sales rise by 13.7%. Adjusted EBIT remains stable. Marketing authorization application submitted for Fibrinogen Concentrate (BT524). Outlook adjusted

Revenue Growth EBIT Biotest AG Product Sales Marketing Authorization
BRIEF

published on 11/14/2024 at 09:01, 1 year ago

Biotest AG Revises Revenue, Cash Flow, and ROCE Forecasts for 2024

Revenue Growth Financial Forecast Biotest AG ROCE EBIT Guidance
BRIEF

published on 11/14/2024 at 09:01, 1 year ago

Biotest AG révise ses prévisions de revenus, de flux de trésorerie et de ROCE pour 2024

Biotest AG ROCE Prévisions Financières Croissance Des Revenus Prévisions EBIT
PRESS RELEASE

published on 11/14/2024 at 08:56, 1 year ago

EQS-Adhoc: Biotest AG: Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged
Biotest AG corrects forecast for revenue, cash flow, and ROCE while maintaining EBIT guidance. Details on the adjustments made for the 2024 financial year disclosed

Revenue Cash Flow Biotest AG ROCE Forecast Correction
BRIEF

published on 10/29/2024 at 09:05, 1 year 1 month ago

Biotest and SteinCares Enhance Access to Hemophilia Treatment in Latin America

Latin America Biotest SteinCares Haemoctin® Hemophilia Treatment
BRIEF

published on 10/29/2024 at 09:05, 1 year 1 month ago

Biotest et SteinCares améliorent l'accès au traitement de l'hémophilie en Amérique latine

L'Amérique Latine Biotest SteinCare Hémoctine® Traitement De L'hémophilie
PRESS RELEASE

published on 10/29/2024 at 09:00, 1 year 1 month ago

Biotest and SteinCares partner to improve access to plasma-derived products in Latin America
Biotest partners with SteinCares to enhance access to plasma-derived products in Latin America, starting with Haemoctin® for hemophilia patients. Financial and strategic collaboration aims to expand commercial footprint in LATAM region

Latin America Biotest Factor VIII SteinCares Plasma-derived Products

Accesswire

Published on 12/05/2025 at 20:25, 17 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 27 minutes ago

When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 52 minutes ago

Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 22 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 57 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 1 hour 44 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 2 hours 15 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 2 hours 26 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 2 hours 50 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 2 hours 56 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 3 hours 24 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 24 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 31 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 31 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 6 hours 43 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE